- Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
Clinical trials
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke -
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia - Investigator
- Mohammad Ilyas
- Ages
- 0 Years - 12 Years
- Sexes
- All
-
Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Patients Hospitalized for Viral Lung Infection Requiring Supplemental Oxygen - Investigator
- Tracy T Ashby
- Ages
- 18 Years - NA Years
- Sexes
- All
-
Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer - Investigator
- Dheeraj R Gopireddy
- Ages
- N/A
- Sexes
- All
-
SUNRAY-02 - Investigator
- Pablo R P Santana
- Ages
- 18 Years - N/A
- Sexes
- All
-
The Connection study (20191002) - Investigators
- Josef Cortez, William R Driscoll, Mark Hudak, Ma Ingyinn, Orlyn C Lavilla, John W Logan, Dawn D McDaniel, Padma S Nandula, Shalinkumar P Patel, Sanket Shah, Renu Sharma, Winston T Sheen
- Ages
- N/A
- Sexes
- All
-
A Multi-Center Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare - Investigator
- Gurjit S Kaeley
- Ages
- 18 Years - 100 Years
- Sexes
- All